Intramedullary spinal cord implantation of human CD34 + umbilical cord-derived cells in ALS

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 5, 2011, Pages 325-330

  Cordes, Anna Lena ^a   Jahn, Kirsten ^b   Hass, Ralf ^b   Schwabe, Kerstin ^a   Weissinger, Eva M ^a   Ganser, Arnold ^a   Götz, Friedrich ^a   Dengler, Reinhard ^a,c   Krauss, Joachim K ^b   Petri, Susanne ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Biochemistry and Tumour Biology Laboratory   (Germany)

^c CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Cellular therapy; Intramedullary spinal cord implantation; Umbilical cord blood

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; CD34 SELECTION; ELECTROMYOGRAPHY; FASCICULATION; FOLLOW UP; HUMAN; IMPLANTATION; INJECTION; INTRAMEDULLARY SPINAL CORD CELL IMPLANTATION; LIMB WEAKNESS; MALE; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPASTICITY; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; WALKING DIFFICULTY;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD34; CORD BLOOD STEM CELL TRANSPLANTATION; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; SPINAL CORD;

EID: 80053969224     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.580850     Document Type: Article

References (22)

1. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585-91. (Pubitemid 24065791)
2. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillé e S, Rule M, et al. Wild-type non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113-7. (Pubitemid 37210700)
3. Miller TM, Cleveland DW. Has gene therapy for ALS arrived? Nat Med. 2003;9:1256-7. (Pubitemid 37279841)
4. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci. 2007;10:608-14. (Pubitemid 46652442)
5. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALSlinked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615-22. (Pubitemid 46652435)
6. Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci. 2007;26:1721-37. (Pubitemid 47493182)
7. Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci. 2000;67:53-9. (Pubitemid 30368622)
8. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE. 2008;3:2494.
9. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007;114: 1395-1406. (Pubitemid 350112275)
10. Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:158-61. (Pubitemid 37184884)
11. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008;265:78-83.
12. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol. 2010;223:229-37.
13. Belzil VV, Valdmanis PN, Dion PA, Daoud H, Kabashi E, Noreau A, et al. Mutations in FUS cause FALS and SALS in French and French-Canadian populations. Neurology. 2009;73:1176-9.
14. Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10:769-82.
15. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, van de Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572-4. (Pubitemid 351601218)
16. Mougeot JL, Richardson-Milazi S, Brooks BR. Wholegenome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved? Trends Mol Med. 2009;15:148-58.
17. Mazzini L, Vercelli A, Mareschi K, Ferrero I, Testa L, Fagioli F. Mesenchymal stem cells for ALS patients. Amyotroph Lateral Scler. 2009;10:123-4.
18. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinfl ammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31:395-405.
19. Nayak MS, Kim YS, Goldman M, Keirstead HS, Kerr DA. Cellular therapies in motor neuron diseases. Biochim Biophys Acta. 2006;1762:1128-38. (Pubitemid 44794369)
20. Knippenberg S, Hass R, Dengler R, Petri S. Intraspinal transplantation of adult stem cells improves motor function and survival in G93A-ALS transgenic mouse model. Amyotroph Lateral Scler. 2009;10(Suppl 1):80.
21. Chen CT, Foo NH, Liu WS, Chen SH. Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-infl ammatory, vasculogenic and neurotrophic mechanisms. Pediatr Neonatol. 2008;49:77-83.
22. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, et al. Intravenous administration of human umbilical cord-blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res. 2003;12:255-70. (Pubitemid 36736737)